Next Article in Journal
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer
Next Article in Special Issue
The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas
Previous Article in Journal
Acute Myeloid Leukemia: Aging and Epigenetics
Previous Article in Special Issue
BRAF V600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma

by
Maria L. Molina
1,2,†,
David García-Bernal
3,†,
Salvador Martinez
2 and
Rut Valdor
1,3,*
1
Brain Regionalization and Development Gene Unit at Biomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain
2
Instituto de Neurociencias UMH-CSIC, CIBERSAM of ISCIII, 03550 San Juan de Alicante, Spain
3
Internal Medicine Department at University of Murcia-Biomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2020, 12(1), 102; https://doi.org/10.3390/cancers12010102
Submission received: 26 November 2019 / Revised: 23 December 2019 / Accepted: 27 December 2019 / Published: 31 December 2019
(This article belongs to the Special Issue Tumors of the Central Nervous System: An Update)

Abstract

Glioblastoma (GB) has been shown to up-regulate autophagy with anti- or pro-oncogenic effects. Recently, our group has shown how GB cells aberrantly up-regulate chaperone-mediated autophagy (CMA) in pericytes of peritumoral areas to modulate their immune function through cell-cell interaction and in the tumor’s own benefit. Thus, to understand GB progression, the effect that GB cells could have on autophagy of immune cells that surround the tumor needs to be deeply explored. In this review, we summarize all the latest evidence of several molecular and cellular immunosuppressive mechanisms in the perivascular tumor microenvironment. This immunosuppression has been reported to facilitate GB progression and may be differently modulated by several types of autophagy as a critical point to be considered for therapeutic interventions.
Keywords: autophagy; chaperone-mediated autophagy; tumor; glioblastoma; perivascular cells; pericytes; immunosuppressive; tumor immune tolerance; autophagy inhibitors autophagy; chaperone-mediated autophagy; tumor; glioblastoma; perivascular cells; pericytes; immunosuppressive; tumor immune tolerance; autophagy inhibitors

Share and Cite

MDPI and ACS Style

Molina, M.L.; García-Bernal, D.; Martinez, S.; Valdor, R. Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma. Cancers 2020, 12, 102. https://doi.org/10.3390/cancers12010102

AMA Style

Molina ML, García-Bernal D, Martinez S, Valdor R. Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma. Cancers. 2020; 12(1):102. https://doi.org/10.3390/cancers12010102

Chicago/Turabian Style

Molina, Maria L., David García-Bernal, Salvador Martinez, and Rut Valdor. 2020. "Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma" Cancers 12, no. 1: 102. https://doi.org/10.3390/cancers12010102

APA Style

Molina, M. L., García-Bernal, D., Martinez, S., & Valdor, R. (2020). Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma. Cancers, 12(1), 102. https://doi.org/10.3390/cancers12010102

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop